BPC-157
BPC-157 (Body Protection Compound 157)
Research Parameters
- Typical Dose Range
- 250 to 500 mcg/day subcutaneous (research standard). Some protocols: 500 mcg twice daily near injury site.
- Half-Life
- ~4 hours (subcutaneous)
- Administration Route
- Subcutaneous, Oral
Dosing information is for research purposes only and has not been evaluated by the FDA.
If you've pulled a hamstring that won't heal, got diagnosed with a chronic tendon issue, or have gut problems that keep flaring up no matter how clean you eat, BPC-157 is the peptide researchers bring up first. It's the one you'll hear about on every recovery-focused podcast for a reason: the animal research on soft tissue healing is some of the strongest in the entire peptide field.
Researchers study it for tendon, ligament, and muscle repair at speeds the body doesn't normally achieve on its own. The gut research is just as compelling. BPC-157 is one of the few peptides studied for both injury recovery and digestive issues, which is why you see it show up in so many protocols.
For research purposes only.
Mechanism of Action
BPC-157 is a 15-amino-acid peptide derived from a protective protein in human gastric juice. The research attributes its effects to angiogenesis (promoting new blood vessel growth to damaged tissue) and upregulation of growth hormone receptors at the injury site. Most of the data is animal research; human trials remain limited.
Citations
Frequently Asked Questions
- What is BPC-157 used for in research?
Research focuses on soft tissue healing: tendons, ligaments, muscle, and the intestinal lining. It's studied for its effects on blood vessel formation and growth factor signaling at injury sites. For research purposes only.
- How does BPC-157 compare to TB-500?
BPC-157 is researched more for localized healing and gut repair, while TB-500 is studied for systemic repair and cell migration. Many research protocols run them together because their mechanisms complement rather than overlap. For research purposes only.
- What is the typical research protocol for BPC-157?
Research protocols commonly use 250 to 500 mcg daily via subcutaneous injection, with some studies dosing near the target tissue. Cycles typically run 4 to 6 weeks. For research purposes only.